Vancomycin infusion reaction: case report
DOI:
https://doi.org/10.11606/issn.1679-9836.v102i1e-199049Keywords:
Vancomycin, Drug-related side effects and adverse reactions, Erythema, Drug hypersensitivityAbstract
Introduction: The vancomycin infusion reaction, previously known as red man syndrome, is an adverse effect usually observed with the use of vancomycin in rapid intravenous infusion and that manifests itself, in most cases, minutes after administration of the first dose of the therapeutic scheme. However, there are rare situations in which this reaction manifests with slow intravenous infusion. In general, this regresses about 20 minutes after vancomycin is discontinued and treatment is instituted, nevertheless, more rarely, it can last from hours to days. Objectives: This study aims to inform, discuss and analyze the relevance of continuous monitoring and individualization of the dosage of this antibiotic, seeking to prevent the occurrence of adverse effects. Method: Case report of a patient who developed an infusion reaction to vancomycin two days after the end of the therapeutic regimen. Results: The patient reported showed partial regression of the adverse effect after nine days of the development of the condition and the institution of therapeutic measures. Conclusion: Thus, in addition to adjusting the dosage of this drug according to renal function, it is extremely important to be aware of the possibility of this adverse reaction occurring in unusual scenarios in medical practice.
Downloads
References
Gupta A, Biyani M, Khaira A. Vancomycin nephrotoxicity: myths and facts. Neth J Med. 2011;69(9):379-83. Available from: https://www.njmonline.nl/getpdf.php?id=1096
Pritchard L, Baker C, Leggett J, Sehdev P, Brown A, Bayley KB. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity. Am J Med. 2010;123(12):1143-9. doi: https://doi.org/10.1016/j.amjmed.2010.07.025
Bruniera FR, Ferreira FM, Saviolli LR, Bacci MR, Feder D, da Luz Gonçalves Pedreira M, Sorgini Peterlini MA, Azzalis LA, Campos Junqueira VB, Fonseca FL. The use of vancomycin with its therapeutic and adverse effects: a review. Eur Rev Med Pharmacol Sci. 2015;19(4):694-700. Available from: https://www.europeanreview.org/article/8585
De Luca JF, Holmes NE, Trubiano JA. Adverse reactions to vancomycin and cross-reactivity with other antibiotics. Curr Opin Allergy Clin Immunol. 2020;20(4):352-61. doi: https://doi.org/10.1097/ACI.0000000000000665
Hicks RW, Hernandez J. Perioperative pharmacology: a focus on vancomycin. AORN J. 2011;93(5):593-6; quiz 597-9. doi: https://doi.org/10.1016/j.aorn.2010.09.031
Peng Y, Li CY, Yang ZL, Shi W. Adverse reactions of vancomycin in humans: a protocol for meta-analysis. Medicine (Baltimore). 2020;99(38):e22376. doi: https://doi.org/10.1097/MD.0000000000022376
Alvarez-Arango S, Ogunwole SM, Sequist TD, Burk CM, Blumenthal KG. Vancomycin infusion reaction - moving beyond “Red Man Syndrome”. N Engl J Med. 2021;384(14):1283-6. doi: https://doi.org/10.1056/NEJMp2031891
Martel TJ, Jamil RT, King KC. Vancomycin Flushing Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482506/
Irani AM, Akl EG. Management and prevention of anaphylaxis. F1000Res. 2015;4:F1000 Faculty Rev-1492. doi: https://doi.org/10.12688/f1000research.7181.1
Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020;77(11):835-64. doi: https://doi.org/10.1093/ajhp/zxaa036.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Maria Paula dos Reis Damasceno, Iasmim Garcia Júlio , Júlia Buzzato Rainer, Auriston Ferraz da Costa

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.